The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
出版年份 2014 全文链接
标题
The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 9, Issue 3, Pages 255-267
出版商
Informa Healthcare
发表日期
2014-02-03
DOI
10.1517/17460441.2014.883377
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inhibition of COX-2 in Colon Cancer Modulates Tumor Growth and MDR-1 Expression to Enhance Tumor Regression in Therapy-Refractory Cancers In Vivo
- (2015) Mahbuba Rahman et al. NEOPLASIA
- Design, synthesis, cytotoxic evaluation and tubulin inhibitory activity of 4-aryl-5-(3,4,5-trimethoxyphenyl)-2-alkylthio-1H-imidazole derivatives
- (2013) Amir Assadieskandar et al. BIOORGANIC & MEDICINAL CHEMISTRY
- PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review
- (2013) A. T. Kunzmann et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
- (2013) Reiko Nishihara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
- (2013) Robert Ramer et al. JOURNAL OF LIPID RESEARCH
- Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole
- (2013) Parisa Miralinaghi et al. MEDICINAL CHEMISTRY RESEARCH
- Design, synthesis, and cytotoxic activities of new 2,4,5-triarylimidazoles
- (2012) A. Zarghi et al. MEDICINAL CHEMISTRY RESEARCH
- Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms
- (2012) Whay Kuang Chia et al. Nature Reviews Clinical Oncology
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic deregulation of the COX pathway in cancer
- (2012) Inês Cebola et al. PROGRESS IN LIPID RESEARCH
- COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status
- (2011) Annika Gustafsson Asting et al. BMC CANCER
- Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells
- (2011) Kim et al. International Journal of Nanomedicine
- Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
- (2011) Rassoul Dinarvand et al. International Journal of Nanomedicine
- Design and synthesis of new 2,4,5-triarylimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors
- (2011) A. Zarghi et al. MEDICINAL CHEMISTRY RESEARCH
- The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer
- (2011) Dingzhi Wang et al. Cancers
- Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy
- (2010) Claudia Cerella et al. BIOCHEMICAL PHARMACOLOGY
- COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-β, IL-10 and Ki67
- (2010) Elin Richardsen et al. Cancer Epidemiology
- Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines
- (2010) Balraj Singh et al. JOURNAL OF SURGICAL RESEARCH
- Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines
- (2010) Claudia Bocca et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor
- (2009) Domenico D'Arca et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Overexpression of ELAV-like Protein HuR is Associated with Increased COX-2 Expression in Atrophy, High-grade Prostatic Intraepithelial Neoplasia, and Incidental Prostate Cancer in Cystoprostatectomies
- (2008) Francesca Barbisan et al. EUROPEAN UROLOGY
- Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
- (2008) Farnaz Esmaeili et al. JOURNAL OF DRUG TARGETING
- Cyclin-dependent kinases and cell-cycle transitions: does one fit all?
- (2008) Helfrid Hochegger et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Selective Inhibition of Cyclooxygenase-2 Suppresses the Growth of Pancreatic Cancer Cells in Vitro and in Vivo
- (2008) Xuan-Fu Xu et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now